Tribe, Drugmaker Heading To Supreme Court After Bids For Rehearing, Stay Denied
WASHINGTON, D.C. — A Native American tribe and a drug company are taking their fight to use the tribe’s sovereign immunity to shield it from inter partes review (IPR) of patents...To view the full article, register now.
Already a subscriber? Click here to view full article